Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No significant changes detected on the page; the NCT02267603 study details for Pembrolizumab in Merkel cell carcinoma remain as published, including the overview and eligibility criteria.
    Difference
    0.3%
    Check dated 2025-11-03T20:42:33.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Update to version v3.2.0 and removal of a specific resource (Cutaneous neuroendocrine carcinoma); addition of an important government-operating status notice and links.
    Difference
    2%
    Check dated 2025-10-06T04:35:14.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-29T01:18:06.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Version bumped to v3.0.2 and the Back to Top element removed. No significant core content changes.
    Difference
    0.1%
    Check dated 2025-09-14T18:47:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T13:14:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of cutaneous neuroendocrine carcinoma and pembrolizumab. Notably, previous terms related to neuroendocrine tumors and various classifications of antineoplastic agents have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:10:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.